Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)-Reference-Cited by-同舟云学术

Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33)

Published:2009-08-20 Issue:11 Volume:23 Page:2153-2155
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Nagel I,Bug S,Tönnies H,Ammerpohl O,Richter J,Vater I,Callet-Bauchu E,Calasanz M J,Martinez-Climent J A,Bastard C,Salido M,Schroers E,Martin-Subero J I,Gesk S,Harder L,Majid A,Dyer M J S,Siebert R

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2009149.pdf

Reference8 articles.

1. Pospisilova H, Baens M, Michaux L, Stul M, Van Hummelen P, Van Loo P et al. Interstitial del(14)(q) involving IGH: a novel recurrent aberration in B-NHL. Leukemia 2007; 21: 2079–2083.

2. Tilly H, Bastard C, Halkin E, Lenormand B, Bizet M, Dauce JP et al. Del(14)(q22) in diffuse B-cell lymphocytic lymphoma. Am J Clin Pathol 1988; 89: 109–113.

3. Annunziata CM, Davis RE, Demchenko Y, Bellamy W, Gabrea A, Zhan F et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 2007; 12: 115–130.

4. Keats JJ, Fonseca R, Chesi M, Schop R, Baker A, Chng WJ et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. Cancer Cell 2007; 12: 131–144.

5. Braggio E, Keats JJ, Leleu X, Van Wier S, Jimenez-Zepeda VH, Valdez R et al. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom′s macroglobulinemia. Cancer Res 2009; 69: 3579–3588.

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuclear Factor-Kappa B Regulation of Osteoclastogenesis and Osteoblastogenesis;Endocrinology and Metabolism;2023-10-31

2. TRAF2/3 deficient B cells resist DNA damage-induced apoptosis via NF-κB2/XIAP/cIAP2 axis and IAP antagonist sensitizes mutant lymphomas to chemotherapeutic drugs;Cell Death & Disease;2023-09-08

3. TRAF3 alterations are frequent in del‐3′ IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features;American Journal of Hematology;2022-05-09

4. The Role of TRAF7 in Tumorigenesis;World Journal of Cancer Research;2022

5. DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis;Blood;2021-12-09